Neurotrophic and neuroprotective actions of an enhancer of ganglioside biosynthesis.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  International review of neurobiology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0074-7742(09)85022-8PMID 19607978
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The synthetic ceramide analog L-PDMP partially protects striatal dopamine levels but does not promote dopamine neuron survival in murine models of parkinsonism.

  2006cited by this paper
• Synchronization of neural activity is a promising mechanism of memory information processing in networks of columns

  2004cited by this paper
• A synthetic ceramide analog ameliorates spatial cognition deficit and stimulates biosynthesis of brain gangliosides in rats with cerebral ischemia.

  2003cited by this paper
• Induction of ganglioside biosynthesis and neurite outgrowth of primary cultured neurons by L-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol.

  2002cited by this paper
• Beneficial effects of GM1 ganglioside on photochemically-induced microvascular injury in cerebral cortex and hypophysis in rat.

  2000cited by this paper
• Attenuation of cortical neuronal apoptosis by gangliosides.

  1999cited by this paper
• Mice lacking complex gangliosides develop Wallerian degeneration and myelination defects.

  1999cited by this paper
• Transient Global Forebrain Ischemia Induces a Prolonged Expression of the Caspase-3 mRNA in Rat Hippocampal CA1 Pyramidal Neurons

  1998cited by this paper
• Promotion of Neuronal Survival by GM1 Ganglioside: Phenomenology and Mechanism of Action

  1998cited by this paper
• Growth factors and gangliosides as neuroprotective agents in excitotoxicity and ischemia.

  1998cited by this paper
• L-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol stimulates ganglioside biosynthesis, neurite outgrowth and synapse formation in cultured cortical neurons, and ameliorates memory deficits in ischemic rats.

  1998cited by this paper
• [Apoptosis in the repeated cerebral ischemia--behavioral & histochemical study].

  1998cited by this paper
• Glucosylceramide Synthase Inhibitor Inhibits the Action of Nerve Growth Factor in PC12 Cells*

  1998cited by this paper
• Expression of a Dominant Negative Mutant of Interleukin-1β Converting Enzyme in Transgenic Mice Prevents Neuronal Cell Death Induced by Trophic Factor Withdrawal and Ischemic Brain Injury

  1997cited by this paper
• Up-regulation of ganglioside biosynthesis, functional synapse formation, and memory retention by a synthetic ceramide analog (L-PDMP).

  1997cited by this paper
• Activation of p42 Mitogen-activated Protein Kinase in Hippocampal Long Term Potentiation*

  1996cited by this paper
• Effects of glucosylceramide synthase inhibitor and ganglioside GQ1b on synchronous oscillations of intracellular Ca2+ in cultured cortical neurons.

  1996cited by this paper
• Immunohistochemical detection of Bax and Bcl-2 proteins in gerbil hippocampus following transient forebrain ischemia.

  1996cited by this paper
• Mice with disrupted GM2/GD2 synthase gene lack complex gangliosides but exhibit only subtle defects in their nervous system.

  1996cited by this paper
• Stimulation of glycosphingolipid biosynthesis by L-threo-1-phenyl-2-decanoylamino-1-propanol and its homologs in B16 melanoma cells.

  1995cited by this paper
• Dynamics of neuronal interactions in monkey cortex in relation to behavioural events

  1995cited by this paper
• Long-Term Spatial Cognitive Impairment after Middle Cerebral Artery Occlusion in Rats: No Involvement of the Hippocampus

  1995cited by this paper
• GM1 ganglioside inhibits ischemic release of amino acid neurotransmitters from rat cortex.

  1995cited by this paper
• Functional roles of gangliosides in bio-signalling

  1995cited by this paper
• ERK2-type mitogen-activated protein kinase (MAPK) and its substrates in postsynaptic density fractions from the rat brain.

  1995cited by this paper
• CNS pharmacology of gangliosides.

  1994cited by this paper
• Overexpression of BCL-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia.

  1994cited by this paper
• Induction of cholinergic differentiation with neurite sprouting by de novo biosynthesis and expression of GD3 and b-series gangliosides in Neuro2a cells.

  1994cited by this paper
• Significance of ganglioside-mediated glycosignal transduction in neuronal differentiation and development.

  1994cited by this paper
• AMPA, but not NMDA, receptor antagonism is neuroprotective in gerbil global ischaemia, even when delayed 24 h.

  1993cited by this paper
• Gangliosides rescue neuronal cells from death after trophic factor deprivation

  1993cited by this paper
• Effects of coencapsulated NGF and GM1 in rats with cortical lesions.

  1993cited by this paper
• Episodic multiregional cortical coherence at multiple frequencies during visual task performance

  1993cited by this paper
• Activation of p42 Mitogen‐Activated Protein Kinase by Glutamate Receptor Stimulation in Rat Primary Cortical Cultures

  1993cited by this paper
• Metabolic effects of inhibiting glucosylceramide synthesis with PDMP and other substances.

  1993cited by this paper
• Periodic synchronized bursting and intracellular calcium transients elicited by low magnesium in cultured cortical neurons.

  1993cited by this paper
• Effects of a sphingolipid synthesis inhibitor on membrane transport through the secretory pathway.

  1992cited by this paper
• Coherent 25- to 35-Hz oscillations in the sensorimotor cortex of awake behaving monkeys.

  1992cited by this paper
• Gangliosides and neuronal differentiation.

  1992cited by this paper
• A novel glycosignaling system: GQ1b-dependent neuritogenesis of human neuroblastoma cell line, GOTO, is closely associated with GQ1b-dependent ecto-type protein phosphorylation.

  1992cited by this paper
• Lactosylceramide stimulates aortic smooth muscle cell proliferation.

  1991cited by this paper
• Correlation of gangliotetraose gangliosides with neurite forming potential of neuroblastoma cells.

  1991cited by this paper
• Stimulation of protein tyrosine phosphorylation by NMDA receptor activation

  1991cited by this paper
• Inhibition of experimental metastasis of murine Lewis lung carcinoma by an inhibitor of glucosylceramide synthase and its possible mechanism of action.

  1990cited by this paper
• "Tracing circuit" model for the memory process in human brain: Roles of ATP and adenosine derivatives for dynamic change of synaptic connections.

  1989cited by this paper
• Effects of D‐threo‐PDMP, an inhibitor of glucosylceramide synthetase, on expression of cell surface glycolipid antigen and binding to adhesive proteins by B16 melanoma cells

  1989cited by this paper
• Oscillatory responses in cat visual cortex exhibit inter-columnar synchronization which reflects global stimulus properties

  1989cited by this paper
• Preparation of the active isomer of 1-phenyl-2-decanoylamino-3-morpholino-1-propanol, inhibitor of murine glucocerebroside synthetase.

  1987cited by this paper
• Long-term enhancement of hippocampal synaptic transmission and the acquisition of spatial information

  1986cited by this paper
• Gangliosides of the neuron

  1985cited by this paper
• GQ1b, a bioactive ganglioside that exhibits novel nerve growth factor (NGF)-like activities in the two neuroblastoma cell lines.

  1983cited by this paper
• A New Model of Bilateral Hemispheric Ischemia in the Unanesthetized Rat

  1979cited by this paper

• Involvement of Lipids in the Pathogenesis of Amyotrophic Lateral Sclerosis

  2023cites this paper
• [The role of sphingolipids in pathogenesis of amyotrophic lateral sclerosis].

  2021cites this paper
• Exploring Sphingolipid Implications in Neurodegeneration

  2020cites this paper
• Overview of Lipid Biomarkers in Amyotrophic Lateral Sclerosis (ALS).

  2019cites this paper
• Morphogenetic Sphingolipids in Stem Cell Differentiation and Embryo Development

  2017cites this paper
• Lipid Involvement in Neurodegenerative Diseases of the Motor System: Insights from Lysosomal Storage Diseases

  2017cites this paper
• Lipidomics of Stem Cells

  2017cites this paper
• Lipidomics Reveals Cerebrospinal-Fluid Signatures of ALS

  2017cites this paper
• Anti-amyloidogenic effects of glycosphingolipid synthesis inhibitors occur independently of ganglioside alterations.

  2016cites this paper
• Glycosphingolipids are modulators of disease pathogenesis in amyotrophic lateral sclerosis

  2015cites this paper
• Inhibition of GSK3β by pharmacological modulation of sphingolipid metabolism occurs independently of ganglioside disturbance in a cellular model of Alzheimer's disease.

  2015cites this paper
• Lysosomal storage diseases and the heat shock response: convergences and therapeutic opportunities

  2014cites this paper
• Thematic review series: Recent advances in the treatment of lysosomal storage diseases

  2014cites this paper
• Ganglioside Biochemistry

  2014cites this paper
• Involvement of Sphingolipids in Ethanol Neurotoxicity in the Developing Brain

  2013cites this paper
• An investigation into the combined effects of β-amyloid toxicity and cerebral ischemia on the pathological expression of gangliosides.

  2012cites this paper
• Glycosphingolipids Regulate Ameloblastin Expression in Dental Epithelial Cells

  2012cites this paper
• Ganglioside Biochemistry

  2012cites this paper
• Neuroplastin Expression in the Hippocampus of Mice Lacking Complex Gangliosides

  2012cites this paper
• Deregulated Sphingolipid Metabolism and Membrane Organization in Neurodegenerative Disorders

  2010cites this paper